Baby formula will remain hard to find until at least mid-July, industry executives said, despite efforts by manufacturers, the White House and regulators to ease a monthslong shortage.
Abbott Laboratories maker of Similac, the largest baby-formula brand by sales in the U.S., resumed production Saturday at its Sturgis, Mich., plant for the first time since February. That factory had produced roughly one-fifth of the infant formula in the country, and left many shelves empty when it issued a recall and paused operations there nearly four months ago.